Connect with us
I have been a pollster for the past 20-plus years, directing what I consider to be the most accurate poll of the last four presidential election...
COVID-19 has already tested our patience, our focus, and our compassion. Now it could be testing our allegiance as well. Two recent studies show that U.S....
Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism, subscribe today. The White House and Democratic...
Seven auto companies have plans to roll out new battery-powered pickup trucks over the next two years, aiming to cash in on a popular and lucrative...
KeyCorp’s 3Q earnings rose 7.9% to $0.41 per share year-on-year helped by lower provision for credit losses. Analysts were looking for EPS of $0.37.KeyCorp’s (KEY) provisions...
Opko Health’s subsidiary BioReference Laboratories has launched a new multiplex test that will aid healthcare providers, clinics and health systems in the diagnosis of COVID-19 and...
In the earnings call, the management explained that improved demand from rural areas, the infrastructure segment, and mid-income or affordable housing boosted revenue in the quarter...
Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke.
Senate Republicans tried to pass an aid bill as Pelosi and Mnuchin negotiate a coronavirus stimulus bill that would cost at least $1.9 trillion.
Near term profits and asset quality could be impacted due to pandemic but the business strengths of the company will help it overcome these headwinds.
Recent Comments